Filing Details

Accession Number:
0001209191-20-037018
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-06-16 17:24:05
Reporting Period:
2020-06-10
Accepted Time:
2020-06-16 17:24:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1394319 Tracon Pharmaceuticals Inc. TCON () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1251371 L Saundra Pelletier C/o Tracon Pharmaceuticals, Inc.
4350 La Jolla Village Drive, Suite 800
San Diego CA 92122
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-06-11 2,500 $2.00 2,500 No 4 P Direct
Common Stock Acquisiton 2020-06-15 3,000 $2.07 5,500 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Director Stock Option (Right to Buy) Acquisiton 2020-06-10 4,500 $0.00 4,500 $2.07
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
4,500 2030-06-09 No 4 A Direct
Footnotes
  1. The shares subject to the option shall vest and become exercisable on the earlier of the first anniversary of the grant date set forth in column 3 above or the date of the next annual meeting of the Company's stockholders.